Condition
Atypical Endometrial Hyperplasia clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Atypical Endometrial Hyperplasia clinical trials that are recruiting, at sites in 2 countries (most in China (7), United States (1)). 1 was first registered in the last 30 days. By phase: Phase 2/3 (4), Phase 2 (1). The most active sponsors are Fudan University (3), Peking University People's Hospital (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1New in 30 days
- 2Countries
Newest Atypical Endometrial Hyperplasia clinical trials
All recruiting trials (8)
-
Liquid biopsy screening for early endometrial cancer in regional China
A non-invasive blood test using cell-free DNA is being tested to see if it can detect early endometrial cancer and tell apart benign from malignant uterine lesions.
-
Intrauterine type III collagen injection plus progestin for fertility-preserving endometrial cancer or atypical hyperplasia
This test sees if adding an intrauterine injection of recombinant humanized type III collagen to high‑dose progestin helps women with early endometrial cancer or atypical hyperplasia preserve fertility and achieve tumor remission.
-
Using GnRHa and Letrozole for Obese Women with Progestin-Insensitive Endometrial Cancer
This study is testing a new treatment combining GnRH antagonist and letrozole to see if it helps obese women with a specific type of endometrial cancer that hasn't responded to standard therapy.
-
Predicting progesterone sensitivity in early endometrial cancer patients
This study is testing a new way to predict how well early endometrial cancer patients will respond to progesterone treatments using their own tumor cells.
-
Combining GnRHa and Letrozole for Non-obese Patients with Endometrial Cancer
This study is testing if a combination of GnRHa and letrozole can help non-obese patients with early-stage endometrial cancer keep their fertility when standard treatments haven't worked.
-
Weight management combined with hormonal treatment for women with endometrial atypical hyperplasia
This study is testing if combining weight management with hormonal treatments can help obese women with endometrial atypical hyperplasia who want to keep their fertility have better treatment results and pregnancy chances.
-
Detecting gynecologic cancers using DNA markers in vaginal fluid and blood
This study is testing a new way to detect endometrial, ovarian, and cervical cancers early by looking for specific DNA markers in the vaginal fluid and blood of women with abnormal bleeding.
-
Using a hormonal device to preserve fertility in patients with early endometrial cancer and atypical hyperplasia
This study is testing if a hormonal device can help women under 40 with early endometrial cancer and atypical hyperplasia keep their fertility while monitoring their health and pregnancy outcomes.
Related topics
Quick answers
How many Atypical Endometrial Hyperplasia clinical trials are recruiting right now?
8, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (7 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2/3: 4, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.